
Archiv der Pharmazie (2020)
Update date:2022-07-29
Topics:
Genc Bilgicli, Hayriye
Taslimi, Parham
Akyuz, Busra
Tuzun, Burak
Gulcin, ?lhami
Heterocyclic compounds are of particular importance among pharmacologically active compounds. In this study, some piperonyl-based 4-thiazolidinone derivatives (2a–i) were synthesized and characterized by spectroscopic assays. All molecules were tested as enzyme inhibitory factors. These compounds were effective inhibitors of the enzymes acetylcholinesterase (AChE), α-glycosidase (α-Gly), and the human carbonic anhydrase I and II isoforms (hCA I and II), with Ki values in the range of 8.90–66.51 nM for α-Gly, 94.8–289.5 nM for hCA I, 106.3–304.6 nM for hCA II, and 0.55–2.36 nM for AChE. The synthesized molecules were also studied theoretically. Molecular docking calculations were performed to investigate the interaction between the target protein and molecules. CA inhibitor compounds have been clinically used for almost 60 years as antiglaucoma and diuretic drugs. The inhibition of the AChE enzyme results in the blockage of ACh hydrolysis. On the contrary, the design of inhibitor compounds or/and modulators for AChE is of major interest as it is one of the most popular tools to prevent Alzheimer's disease.
View MoreXiamen Goodhealth Pharmchem Co., Ltd.
Contact:0086-592-2097683
Address:404R No.2 54# Minzu Rd., Xiamen, China
ZiBO KuoDing Trade company Ltd
website:http://www.sdzbkd.com
Contact:86-13361591822
Address:GongQingTuan road
Shanghai shibo Chemical Co., Ltd
Contact:+86-021-60753516
Address:688 Qiushi Road, Jinshan High-tech Park, Shanghai, China,201512
SINO Industries Company Limited(expird)
Contact:86-29-85369724
Address:No.111, Jiefang Road, Xi’an, China
Jinan Hongfangde Pharmatech Co.,Ltd
Contact:86-531-88870908
Address:F Bldg. West Unit North Area of Univ. Tech. Garden Xinyu Rd. Jinan New & High Tech Industry Development Zone Shandong, China
Doi:10.1002/(sici)1099-0690(199909)1999:9<2149::aid-ejoc2149>3.0.co;2-d
(1999)Doi:10.1021/jo005562f
(2000)Doi:10.1023/B:COHC.0000018342.57499.16
(2003)Doi:10.1080/15533170701316494
(2007)Doi:10.1021/jm9905413
(2000)Doi:10.1002/ejoc.200400699
(2005)